Research Article

Functional Bowel Disorders Are Associated with a Central Immune Activation

Table 3

Predictors of IBS-SSS. The covariates in the analyses were the groups (neurological/depression), depression (BDI-II), and one by one of the other variables.

GroupBDI-IIOther variables
B (95% CI) valueB (95% CI) valueB (95% CI) value

86 (31; 141)0.003
28 (−45; 102)0.4442.4 (0.3; 4.6)0.027
23 (−51; 98)0.5332.6 (0.4; 4.7)0.021Gender (male)24 (−24; 73)0.317
23 (−51; 98)0.5292.8 (0.6; 5.0)0.015Age (years)1.0 (−0.7; 2.8)0.252
28 (−46; 102)0.4542.4 (0.2; 4.6)0.031IL-10 serum (pg/ml)−1.5 (−12.6; 9.6)0.787
30 (−45; 105)0.4292.4 (0.3; 4.6)0.029TNF serum (pg/ml)0.8 (−3.9; 5.4)0.745
24 (−51; 99)0.5262.4 (0.3; 4.6)0.028TNF/IL-10 ratio serum1.8 (−3.2; 6.8)0.480
23 (−54; 99)0.5512.3 (0.0; 4.5)0.048IL-10-CSF (pg/ml)−69 (−146; 9)0.084
30 (−46; 106)0.4322.5 (0.3; 4.7)0.024TNF-CSF (pg/ml)32 (3; 61)0.030
33 (−42; 108)0.3802.2 (0.0; 4.4)0.046TNF/IL-10 ratio CSF55 (13; 97)0.012
21 (−58; 101)0.5952.7 (0.5; 2.0)0.020Kynurenine serum0.5 (−46.2; 47.1)0.984
24 (−53; 102)0.5302.6 (0.4; 4.9)0.021Tryptophan serum−1.4 (−3.5; 0.7)0.194
17 (−61; 95)0.6682.8 (0.5; 5.0)0.017K/T × 1000 serum1.3 (−1.2; 3.8)0.304
34 (−44; 111)0.3872.4 (0.2; 4.6)0.034Kynurenine CSF (pg/ml)>10.062
22 (−56; 100)0.5772.8 (0.6; 5.0)0.015Tryptophan CSF (pg/ml)>10.150
21 (−57; 99)0.5892.7 (0.5; 5.0)0.019K/T × 1000 CSF−0.3 (−2.6; 2.0)0.797
40 (−42; 122)0.3322.6 (−0.2; 5.3)0.065Propionic acid faeces (mmol/l)1.9 (−20.7; 24.4)0.869
35 (−47; 118)0.3902.5 (−0.2; 5.2)0.070Butyric acid faeces (mmol/l)−7.2 (−27.7; 13.2)0.481
22 (−58; 102)0.5802.4 (−0.1; 5.1)0.063PmB faeces (mmol/l)44 (−0.4; 87.6)0.052

Fractional polynomial linear regression. BDI-II: Beck Depression Inventory-II; IL-10 serum: interleukin 10 in the serum; TNF serum: tumor necrosis factor in serum; IL-10-CSF: interleukin 10 in the cerebrospinal fluid; TNF-CSF: tumor necrosis factor in the cerebrospinal fluid; PmB: propionic acid minus butyric acid in faeces; K/T ratio × 1000: kynurenine/tryptophan ratio × 1000.